Navigation Links
Study finds air traffic control tracking method reduces errors in trauma management
Date:6/11/2009

CHICAGO (June 11, 2009) New research published in the June issue of the Journal of the American College of Surgeons shows that a method used by air traffic controllers tracks patient data more effectively and with fewer errors compared with current hospital methods, primarily the use of clipboards.

Currently there is no standard practice for tracking the movement of patients from emergency rooms to the radiology suite, operating rooms, the intensive care unit, inpatient rooms or the discharge area. In addition, basic errors such as misidentifying which extremity needs to be amputated have resulted in increased mortality that could be prevented with basic safety measures. Both of these situations underscore the fact that patient safety has become a more visible vulnerability of modern medicine.

Air traffic controllers use a method in which each aircraft is represented by a flight progress strip. Multiple strips are stacked in order of priority within a bay representing a unique stage of flight. Reprioritization regularly occurs for faster aircraft or those that require expedited throughput for emergency or other reasons such as low fuel or weather. Flight progress strips are moved from bay to bay as aircraft move from one stage of flight to another.

"For decades, air traffic controllers have managed the complexities of airspace and aircraft handoff with a simple, manual method that has evolved to an efficient and nearly flawless system," says Jason D. Hoskins, MA, of the Uniformed Services University of the Health Sciences (USUHS) in Maryland. "Our study successfully demonstrated that this method translates to trauma management, and results in increased accuracy and awareness of patient recording, tracking and throughput management. We are currently in discussions to test a more mature version of the system in clinic."

Researchers compared the air traffic control model and the traditional casualty tracking method of
'/>"/>

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
Weber Shandwick Worldwide
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study shows promise for new cancer-stopping therapy
2. Study finds segregation decreases access to surgical care for minorities
3. Kessler Foundation Research Center Study Provides Insight into One of the Most Challenging Symptoms Following a Traumatic Brain Injury
4. Kessler Foundation Research Center Study Provides Insight into One of the Most Challenging Symptoms Following a Traumatic Brain Injury
5. PAREXEL Enhances Study Start-Up and Recruitment Capabilities With Appointment of Dr. Lars-Olof Eriksson, Formerly With Merck
6. Want to Learn How to Testify? New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effective in Court
7. Morning Sickness Drug Gets Green Light in Study
8. DaVita Study Demonstrates Clinical Application of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter
9. New Study Shows Coaching to Patient Activation Levels Improves Disease Management Outcomes
10. New Jefferson study may redefine how a chronic auto-immune disease is diagnosed
11. ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ire/--Thanksgivingmealswillbedeliveredtoapproximat...hankstoFaithInAction/VolunteerActionforAging,aprog...ANHealthPlan.Formorethan17yearstheseorganizationsh...givingmealstoseniorsinneedinLongBeach,Lakewood,Sig...es. ,, "Ourwarmholidaymealsaredeliveredtopeople...
(Date:11/25/2009)...cer who were treated with cisplatin-based chemothe...logical side effects and Raynaud-like phenomena, t...cording to a new study published online November 2... . , Marianne Brydy, M.D., of the Department of ..., Norway, and colleagues conducted a cross-section...
(Date:11/25/2009)...toid arthritis, could help newly diagnosed diabeti...HealthDay News) -- A drug commonly used to treat n... also shows some promise in helping patients newly...tuximab (Rituxan), helped patients keep producing ... had destroyed some of their pancreatic beta cells...
(Date:11/25/2009)...SSIONSkincare ®isproudtosupportGNC,seffortsto...alSt.Jude ThanksandGiving campaign,$1fromthepurcha...LipBalm willbedonatedtoSt.Jude.Additionally,GNCcus...tcheckoutatoneoftheir5,000+retaillocationsoratGNC....ngtheir2009 ThanksandGiving campaign. ,, "Weare...
(Date:11/25/2009)...n occur in children with autism and related condit...ludes medication combined with a structured traini...ty researchers and their colleagues. , Publishe...e American Academy of Child and Adolescent Psychia...itute of Mental Health (NIMH) Research Units on Pe...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2
...Kathy Morning Show On 101.9fm THE MIX/WTMX ...URNEE, Ill., Oct. 2 Most young boys spend their,s...g presents.,Unfortunately one local boy, Jake Robe...ma on May 27, 2005, when he was,just four years ol...
...ldren against Human Papilloma Virus (HPV) - the fi...ted infection - will be discussed at the National ... today (1515hrs, Tuesday 2 October). , Professor ...a Brabin, who is leading a pilot study into the ac...
...ery device investigated by University of Missouri-...scus tears, which were previously defined as irrep...mans. , Previous treatment options forced surgeo...e. Herb Schwartz, president and CEO of Schwartz Bi...
...udden cardiac death , TUESDAY, Oct. 2 (HealthDay N... along with a beta blocker, may help reduce certai... Marfan syndrome, research shows. , Marfan syndrom... system abnormalities. Progressive dilation and ru...
...eive the lifesaving devices, studies find , ...less likely than men to receive implantable defibr...white patients to receive the lifesaving heart dev...the mid 1990s, the Institute of Medicine noted tha...
...s Announced Today to $600 Million, New Commitments... of 2009, VALENCIA, Calif., Oct. 2 MannKind Corp...as entered into a new loan,arrangement with Alfred...til December 31, 2009. The loan can be drawn down ...
Other Medicine News:Health News:Super Jake Foundation Hosts 3rd Annual 'Heroes Bash' on Nov. 3 to Benefit Pediatric Cancer Research 2Health News:Super Jake Foundation Hosts 3rd Annual 'Heroes Bash' on Nov. 3 to Benefit Pediatric Cancer Research 3Health News:FDA approves knee-injury device for humans 2Health News:Drug Combo Helps Fight Marfan Syndrome 2Health News:Women Less Likely to Get Heart Defibrillators 2Health News:Women Less Likely to Get Heart Defibrillators 3Health News:MannKind Announces New $350 Million Credit Facility 2Health News:MannKind Announces New $350 Million Credit Facility 3
(Date:11/25/2009)...NESBURG,November25/PRNewswire/--,iThembaPharmaceut...ay,thattheyhavesignedacollaborativeagreementtojoin...rldclasscomputationalchemistryandleaddiscoveryexpe...rovidemedicinaland,syntheticchemistrysupporttoproj...work.iThembaPharmaceuticalsandPyxisDiscovery,alsoa...
(Date:11/24/2009)...re-Asia/--ChindexInternational,Inc.,("Chindex")(Na...Western,healthcareproductsandservicesinthePeople,s...ttendthe21stAnnualPiperJaffray,"Unplugged"HealthCa...kPalaceHotel. , Managementiscurrentlyschedule...holdone-on-onemeetingsthroughouttheday.Awebcast,of...
(Date:11/24/2009)...re-FirstCall/--QuestDiagnosticsIncorporated(NYSE: ...,informationandservices,announcedthatitisscheduled...enceinNewYorkCity.ThepresentationisscheduledforWed...Duringtheconference,thecompanywillreaffirmits2009g...cometoexceed18%ofrevenues,anddilutedearningspersha...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Chindex International to Present at Piper Jaffray Health Care Conference 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2invivodata Announces ePROficiency 2009 Web Seminar Series 12541 1invivodata Announces ePROficiency 2009 Web Seminar Series 12541 2RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment 48282 1RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment 48282 2RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment 48282 3Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 1Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 2Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 3Empire BlueCross BlueShield Adds Life Insurance Becomes Full Service Benefits Provider 48280 4
...MFIELD, N.J., March 26, 2007 /PRNewswire-FirstCall...vivo study results,demonstrating the potential of ...ll cell lung cancer (NSCLC) were recently,publishe...ased on the work of Intae Lee, Ph.D., at the Unive... Efficacy of the Cytotoxic,RNase, Ranpirnase, on A...
...ETON, N.J.--(BUSINESS WIRE)--Mar 26, 2007 - Cytoge...five abstracts will,be presented or published at u...ude various Phase 1 clinical results for QUADRAMET...ination settings for,the treatment of metastatic b...ple myeloma, as well as data from a study,evaluati...
Other Medicine Technology:In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 2In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 3New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 2New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 3New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 4New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 5
Spyglass
8F Standard
5F Infiniti
Leksell Neuro Generator
Medicine Products: